Enhancing Exercise Training for Adults With COPD

NCT04704310 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2021-09-02

No results posted yet for this study

Summary

This study aims to find a new way to get individuals living with COPD to become and stay active during and after an exercise intervention. In this study, individuals living with COPD will participate in an online exercise intervention. The exercises included in this intervention are based in individuals' activities of daily living. Additionally, during this intervention, individuals with COPD will participate in peer support sessions and will be taught and encouraged to discuss eight behaviour change techniques that have been shown to help support increased participation in physical activity and/or exercise. The goal of this study is to test out this new protocol and determine if it is feasible to recreate on a larger scale and if it is acceptable for the COPD community.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

BEHAVIORAL

Enhancing exercise training for adults with COPD: The roles of peers and functional tasks

A proof-of-concept online 8-week exercise training program for adults with COPD that incorporates both a peer mentorship and a functional tasks component.

Sponsors & Collaborators

  • Fondation Québécoise en Santé Respiratoire

    collaborator UNKNOWN
  • McGill University

    lead OTHER

Principal Investigators

  • Shane N Sweet, Ph.D · McGill University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-27
Primary Completion
2021-04-15
Completion
2021-04-15

Countries

  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04704310 on ClinicalTrials.gov